BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10100133)

  • 21. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM
    Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menstrual cycle patterns and risk of breast cancer.
    Whelan EA; Sandler DP; Root JL; Smith KR; Weinberg CR
    Am J Epidemiol; 1994 Dec; 140(12):1081-90. PubMed ID: 7998590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women's preferences for menstrual bleeding frequency in 12 European countries: the Inconvenience Due to Women's Monthly Bleeding (ISY) survey.
    Fiala C; Chabbert-Buffet N; Häusler G; Jamin C; Lete I; Lobo P; Nappi RE; Pintiaux A
    Eur J Contracept Reprod Health Care; 2017 Aug; 22(4):268-273. PubMed ID: 28650776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menstrual factors in relation to breast cancer risk.
    Titus-Ernstoff L; Longnecker MP; Newcomb PA; Dain B; Greenberg ER; Mittendorf R; Stampfer M; Willett W
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):783-9. PubMed ID: 9752986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women's Knowledge of Ovulation, the Menstrual Cycle, and Its Associated Reproductive Changes.
    Ayoola AB; Zandee GL; Adams YJ
    Birth; 2016 Sep; 43(3):255-62. PubMed ID: 27157718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reducing the frequency of menses: extended contraception, a review].
    This P
    Gynecol Obstet Fertil; 2013 Jun; 41(6):381-7. PubMed ID: 23769012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myths and Methodologies: Reducing scientific design ambiguity in studies comparing sexes and/or menstrual cycle phases.
    Sims ST; Heather AK
    Exp Physiol; 2018 Oct; 103(10):1309-1317. PubMed ID: 30051938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of oral contraceptive use predicts women's initial and subsequent subjective responses to sexual stimuli.
    Renfro KJ; Rupp H; Wallen K
    Horm Behav; 2015 Sep; 75():33-40. PubMed ID: 26204805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MR-imaging of the breast at 0.5 Tesla: menstrual-cycle dependency of parenchymal contrast enhancement in healthy volunteers with oral contraceptive use?].
    Lorenzen J; Welger J; Lisboa BW; Krupski G; Adam G
    Rofo; 2003 Apr; 175(4):502-6. PubMed ID: 12677505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antichlamydial activity of cervical secretion in different phases of the menstrual cycle and influence of hormonal contraceptives.
    Mahmoud EA; Hamad EE; Olsson SE; Mårdh PA
    Contraception; 1994 Mar; 49(3):265-74. PubMed ID: 8200220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncontraceptive health benefits of oral steroidal contraceptives.
    Mishell DR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women's soccer injuries in relation to the menstrual cycle and oral contraceptive use.
    Möller-Nielsen J; Hammar M
    Med Sci Sports Exerc; 1989 Apr; 21(2):126-9. PubMed ID: 2709976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menstruation: choosing whether...and when.
    Kaunitz AM
    Contraception; 2000 Dec; 62(6):277-84. PubMed ID: 11239613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.
    Matthews KA; Santoro N; Lasley B; Chang Y; Crawford S; Pasternak RC; Sutton-Tyrrell K; Sowers M
    J Clin Endocrinol Metab; 2006 May; 91(5):1789-95. PubMed ID: 16492698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of breast cancer.
    Marchant DJ
    Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
    Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus.
    Short RV; Lewis PR; Renfree MB; Shaw G
    Lancet; 1991 Mar; 337(8743):715-7. PubMed ID: 1672186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.